NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−689k kr).
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−52k kr).
NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS is registered as a limited company in Nordre Follo, Akershus with organisation number 962215718. The business is classified under wholesale of chemical products (NACE 46.850). The company was incorporated in 1991. Registered share capital is NOK 450,000, divided into 1000 shares. The company's stated purpose is: “Produksjon og salg av tjenester, varer og teknologi knyttet til kjemiske produkter, råvarer til legemidler og elektronikk. Analytisk virksomhet i forbindelse med forskning og industriell utvikling. Publikasjon av vitenskapelige, tekniske og populære tidsskrifter og bøker og veiledning i alt som forbundet til publiseringsvirksomhet”.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS?
NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS has 2 registered shareholders:
- LARYSA KARALIOVA 50.0%
- ILIA BRONDZ 50.0%
Frequently asked questions about NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS
Who owns NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS?
LARYSA KARALIOVA is the largest registered owner, with 50.0%.
Who is the general manager of NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS?
Ilia Brondz is registered as general manager of NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS.
Where is NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS based?
NORWEGIAN DRUG CONTROL AND DRUG DISCOVERY INSTITUTE (NDCDDI) AS has its business address in Ski.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.